Shots:
- Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare.
- This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health.
- In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding 32 healthcare and biotech companies to its portfolio. For the complete report, reach out to us at connect@pharmashots.com.
Founded in 1996, Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, a leading publicly traded real estate investment trust (REIT) based in California, United States. Named after the historic Egyptian city of Alexandria, renowned for its scientific and scholarly legacy, the firm reflects a deep-rooted commitment to advancing innovation in science and technology.
In 2024, Alexandria Venture participated in six funding rounds across various stages, including Seed, Series A–C, Series E, and Series F & beyond, along with three private funding rounds. Notable additions to its portfolio include:
- nChroma Bio
- AXONIS Therapeutics
- Terray Therapeutics
- Judo Bio
The firm’s largest single investment was a $400M Series A round in Mirador Therapeutics.
Alexandria Venture focuses exclusively on early- to growth-stage life sciences companies, with a strong emphasis on breakthrough innovations in biotechnology, pharmaceuticals, diagnostics, and digital health.
Therapeutic Areas of Focus:
- Oncology
- Infectious diseases
- Neurology
- Immunology
Technological Focus:
- Antibodies
- Small molecules
- Cell and gene therapies
- Immunotherapies
- Peptides
- Antibody conjugates
In 2024:
- Invested in 32 companies
- 34.37% of investments were through Series A
- 25% were through Seed
Key Investments in 2024:
- $400M Series A - Mirador Therapeutics
- $175M Series B - Capstan Therapeutics
- $161M Series B - Nuvig Therapeutics
Quarterly Investments in 2024:
- Q1: 6 investments worth $980M
- Q2: 8 investments worth $496.1 M
- Q3: 5 investments worth $419M
- Q4: 13 investments worth $810.4M
The table below depicts the top 5 out of the 32 investments made by Alexandria Venture Investment:
Note: (For a complete report, reach out to us at connect@pharmashots.com with the subject line “Alexandria Venture” or for early access to complete data for future reports and analysis, register here: https://forms.office.com/r/VwFu6aUm80)
Related Post: Know Your Investor (May Edition): Alexandria Venture Investment
